Matinas Biopharma Holdings I

Penny Stocks Biotech Stocks Healthcare Stocks

$0.90

-0.02 (-2.00%)

As of Nov 14, 2:52 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +4,270.0% upside

Low Target $22.47

Average Target $39.33

High Target $48.65

Current Price $0.90

Current
$0.90

Target
$39.33

$22.47 $39.33 avg $48.65

Scenario Analysis

Bear Case

$22.47

2,396.7%

Low target

Base Case

$39.33

+4,270.0%

Avg target

Bull Case

$48.65

+5,305.6%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$19.50

-95.4% from high

52-Week Low

$0.81

+11.5% from low

Target vs 52W High

$39.33

+101.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%